Abstract

Research suggests that the use of dexmedetomidine (DEX)improves patient outcomes during alcohol withdrawal, including decreased intubation time and reduction in alcohol withdrawal symptoms. A retrospective chart review of adult patients in ICU with alcohol withdrawal was completed. It was determined that a DEX evidence-based medication regimen was not regularly implemented.

Authors

Susan E. Becker

Author Details

Susan E. Becker, DNP, Malek School of Health Professionals, Marymount University, Arlington, Virginia, USA

Sigma Membership

Eta Alpha

Lead Author Affiliation

Marymount University, Arlington, Virginia, USA

Type

Poster

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Alcohol Withdrawal, Evidence-based Practice, Medication Protocol

Conference Name

29th International Nursing Research Congress

Conference Host

Sigma Theta Tau International

Conference Location

Melbourne, Australia

Conference Year

2018

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (296 kB)

Share

COinS
 

Retrospective review comparing three pharmacological methods of treating alcohol withdrawal patients in ICU

Melbourne, Australia

Research suggests that the use of dexmedetomidine (DEX)improves patient outcomes during alcohol withdrawal, including decreased intubation time and reduction in alcohol withdrawal symptoms. A retrospective chart review of adult patients in ICU with alcohol withdrawal was completed. It was determined that a DEX evidence-based medication regimen was not regularly implemented.